Shenzhen Xinhao Photoelectricity Technology Co., Ltd

SZSE:301051 Stok Raporu

Piyasa değeri: CN¥4.4b

Shenzhen Xinhao Photoelectricity Technology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Shenzhen Xinhao Photoelectricity Technology has a total shareholder equity of CN¥2.7B and total debt of CN¥1.4B, which brings its debt-to-equity ratio to 53.7%. Its total assets and total liabilities are CN¥4.9B and CN¥2.3B respectively.

Anahtar bilgiler

53.7%

Borç/özkaynak oranı

CN¥1.42b

Borç

Faiz karşılama oranın/a
NakitCN¥766.17m
EşitlikCN¥2.65b
Toplam yükümlülüklerCN¥2.28b
Toplam varlıklarCN¥4.93b

Son finansal sağlık güncellemeleri

Recent updates

We Think Shenzhen Xinhao Photoelectricity Technology (SZSE:301051) Has A Fair Chunk Of Debt

Oct 02
We Think Shenzhen Xinhao Photoelectricity Technology (SZSE:301051) Has A Fair Chunk Of Debt

Is Shenzhen Xinhao Photoelectricity Technology (SZSE:301051) Using Too Much Debt?

Jun 26
Is Shenzhen Xinhao Photoelectricity Technology (SZSE:301051) Using Too Much Debt?

Shareholders Will Be Pleased With The Quality of Shenzhen Xinhao Photoelectricity Technology's (SZSE:301051) Earnings

Apr 05
Shareholders Will Be Pleased With The Quality of Shenzhen Xinhao Photoelectricity Technology's (SZSE:301051) Earnings

Is Shenzhen Xinhao Photoelectricity Technology (SZSE:301051) A Risky Investment?

Feb 29
Is Shenzhen Xinhao Photoelectricity Technology (SZSE:301051) A Risky Investment?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 301051's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥1.9B).

Uzun Vadeli Yükümlülükler: 301051's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥347.7M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 301051's net debt to equity ratio (24.8%) is considered satisfactory.

Borcun Azaltılması: 301051's debt to equity ratio has increased from 9.2% to 53.7% over the past 5 years.

Borç Kapsamı: 301051's debt is not well covered by operating cash flow (17.3%).

Faiz Kapsamı: Insufficient data to determine if 301051's interest payments on its debt are well covered by EBIT.


Bilanço


Sağlıklı şirketleri keşfedin